Intra-individual Comparison of Efficacy and Safety of Metvix(R) Natural Daylight Photodynamic Therapy Versus Conventional Metvix(R) Photodynamic Therapy in Subject With Mild Actinic Keratoses.
Phase of Trial: Phase III
Latest Information Update: 20 Apr 2016
At a glance
- Drugs Methyl aminolevulinate (Primary)
- Indications Actinic keratosis
- Focus Therapeutic Use
- Acronyms CoMet
- Sponsors Galderma
- 01 Mar 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 06 Jun 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 20 Mar 2012 Additional lead trial investigator identified as reported by ClinicalTrials.gov.